Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Analyzing ACGL Stock – A Market Insight Brief

Shares of Arch Capital have moved 0.4% today, and are now trading at a price of $89.97. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 162,928 compared to the stock's average volume of 2,281,396.

Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products in the United States, Canada, Bermuda, the United Kingdom, Europe, and Australia. Based in Pembroke, Bermuda the company has 7,200 full time employees and a market cap of $33,578,604,544.

The company is now trading -16.93% away from its average analyst target price of $108.31 per share. The 16 analysts following the stock have set target prices ranging from $93.0 to $125.0, and on average give Arch Capital a rating of buy.

Over the last 12 months ACGL shares have declined by -18.4%, which represents a difference of -35.6% when compared to the S&P 500. The stock's 52 week high is $116.47 per share and its 52 week low is $82.49. Based on Arch Capital's average net margin growth of 0.5% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 17,440,000 4,312,000 25 -24.24
2023 13,634,000 4,443,000 33 120.0
2022 9,613,000 1,476,000 15 -34.78
2021 9,248,000 2,157,000 23 35.29
2020 8,508,509 1,405,521 17 -29.17
2019 6,925,967 1,636,319 24
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS